Stocks · News reference

Cyclerion Therapeutics Announces September 4 Record Date For Contingent Value Rights Distribution To Common And Series A Preferred Holders In Connection With Planned Korsana Biosciences Merger

Aug 25, 2026, 8:18 PMBenzinga News-desk

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001755237/000119312526365150/d376250d8k.htm

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARAug 27, 2026, 10:01 AMSEC EDGAR
8-K filing — Cyclerion Therapeutics, Inc. (CYCN)
Filed: 2026-08-27 AccNo: 0001193125-26-369426 Size: 202 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Read original at edgar
CYCN